Determinants of omalizumab drug survival in a long‐term daily practice cohort of patients with chronic urticaria.
LS Spekhorst, JMPA van den Reek, AC Knulst… - Allergy, 2019 - search.ebscohost.com
The article offers information on the drug survival of omalizumab in a large daily practice
cohort of patients with chronic urticaria (CU) and identified determinants of drug survival in …
cohort of patients with chronic urticaria (CU) and identified determinants of drug survival in …
Изменения клеточного и гуморального иммунитета у пациентов с холодовой и хронической спонтанной крапивницей
ВВ Янченко, ОГ Величинская - Вестник Витебского …, 2015 - cyberleninka.ru
Цель исследования оценка клеточного и гуморального звена системы иммунитета у
пациентов с холодовой и хронической спонтанной крапивницей. Материалы и методы …
пациентов с холодовой и хронической спонтанной крапивницей. Материалы и методы …
Evaluation of the effectiveness of anti-IgE treatment in patients with chronic urticaria with an urticarial control test
G Aytekin, F Colkesen, E Yildiz, S Arslan - 2019 - annalsmedres.org
Aim: Chronic spontaneous urticaria (CSU) is characterized by recurrent urticaria,
angioedema and a combination of both over a period of more than 6 weeks. Anti …
angioedema and a combination of both over a period of more than 6 weeks. Anti …
Diagnostics and treatment of chronic urticaria in the family doctor's office
A Malita, A Fabian-Danielewska - Journal of Education, Health and …, 2018 - apcz.umk.pl
Urticaria is classified as a sever, chronic, allergic disease with a phase of remission and
exacerbation. The basic dermatitis is wheal. The classification of urticaria is based on the …
exacerbation. The basic dermatitis is wheal. The classification of urticaria is based on the …